Spyre Therapeutics, Inc. revenue breakdown overview

Spyre Therapeutics, Inc. revenue for the last year amounted to 886.00 k USD, the most of which — 886.00 k USD — came from its highest performing source at the moment, Human Enzyme Therapeutics, the year earlier bringing 2.33 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Spyre Therapeutics, Inc. 886.00 k USD, and the year before that — 2.33 M USD.